Prevacus partners with Blinktbi for advanced concussion drug trials
Prevacus, a leading US biopharmaceutical company, has announced a strategic partnership with medical device company Blinktbi, utilizing their novel EyeStat device to measure brain function objectively during a Phase 1 clinical trial of a new concussion drug. This collaboration highlights a significant advancement in the treatment and understanding of mild traumatic brain injuries (mTBI) and […]